Cite
HARVARD Citation
Godard, F. et al. (2022). Cerebellum/liver index in pretherapeutic 18F-FDG PET/CT as a predictive marker of progression-free survival in follicular lymphoma treated by immunochemotherapy and rituximab maintenance. Medicine. 101 (5), p. . [Online].